JP3152402B2 - Antitumor agent and method for producing the same - Google Patents

Antitumor agent and method for producing the same

Info

Publication number
JP3152402B2
JP3152402B2 JP18809991A JP18809991A JP3152402B2 JP 3152402 B2 JP3152402 B2 JP 3152402B2 JP 18809991 A JP18809991 A JP 18809991A JP 18809991 A JP18809991 A JP 18809991A JP 3152402 B2 JP3152402 B2 JP 3152402B2
Authority
JP
Japan
Prior art keywords
alcohol
weight
yamabushitake
antitumor
hot water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP18809991A
Other languages
Japanese (ja)
Other versions
JPH0517366A (en
Inventor
恭広 佐藤
武志 飯森
洵 八代
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Paper Industries Co Ltd
Original Assignee
Nippon Paper Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Paper Industries Co Ltd filed Critical Nippon Paper Industries Co Ltd
Priority to JP18809991A priority Critical patent/JP3152402B2/en
Publication of JPH0517366A publication Critical patent/JPH0517366A/en
Application granted granted Critical
Publication of JP3152402B2 publication Critical patent/JP3152402B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は軟質担子菌ヒダナシタケ
目サンゴハリタケ属ヤマブシタケの子実体または液体培
養菌糸の熱水抽出液を有効成分として含有する抗腫瘍剤
及びその製法の関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an antitumor agent containing, as an active ingredient, a fruiting body of a soft basidiomycete Hydanashitake Coralum genus Yamabushitake or a hot water extract of a liquid culture mycelium, and a method for producing the same.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】ヤマブ
シタケ自体は食用キノコであり、日本にも存在している
が、中国においては猿頭菌毛(ユーユーキンヘ)と呼ば
れ健康食品として利用されており、その効能としては体
力増強、血圧降下作用、免疫回復作用などがあると言わ
れている。
2. Description of the Related Art Yamabushitake itself is an edible mushroom, which is also present in Japan, but is called monkey head hair (yuyukinhe) in China and is used as a health food. It is said that its effects include physical strength enhancement, blood pressure lowering, and immune recovery.

【0003】従来より担子菌類の子実体や培養菌糸から
分離される多糖類や多糖蛋白複合体の抗腫瘍活性につい
ては極めて多くの研究がなされており、それ等の中には
抗腫瘍剤として実用化されているものもある。しかし、
それ等の中には抗腫瘍活性がそれ程強くないものも多
く、その有効性が疑問視され最近見直しによる薬効の限
定が行われている状況にある。また軟質担子菌類の抗腫
瘍活性については全く知られていなかった。
[0003] There have been a great many studies on the antitumor activity of polysaccharides and polysaccharide protein complexes isolated from fruiting bodies of basidiomycetes and cultured mycelium, and some of them have been practically used as antitumor agents. Some have been converted. But,
Many of them do not have very strong antitumor activity, and their effectiveness is questioned, and the drug efficacy has recently been limited by review. Also, the antitumor activity of soft basidiomycetes was not known at all.

【0004】[0004]

【課題を解決するための手段】本発明者等はより有効な
キノコの探索を広く海外のものも含めて行ってきた。
Means for Solving the Problems The present inventors have widely searched for more effective mushrooms, including those from overseas.

【0005】その結果、本発明者等は中国において猿頭
菌毛(ユーユーキンヘ)と呼ばれ健康食品として使われ
ている軟質担子菌類の和名ヤマブシタケの子実体及び培
養菌糸の熱水抽出液中の成分が極めて著しい抗腫瘍作用
を有することを見出だし、鋭意検討した結果、本発明を
完成した。
[0005] As a result, the present inventors have found that the fruit body of the soft basidiomycete, the Japanese name Yamabushitake, and a cultured mycelium of a soft mycelia fungus called Yuyukinhe, which is used as a health food in China, is contained in the hot water extract. The present inventors have found that the component has an extremely remarkable antitumor effect, and as a result of intensive studies, completed the present invention.

【0006】即ち本発明の抗腫瘍剤は、ヤマブシタケの
子実体又は液体培養菌糸の熱水抽出液またはその濃縮液
1重量部に対し、 0.5〜5重量部のアルコールを加え、
生成するアルコール沈殿画分を有効成分とすることを特
徴とするものである。
That is, the antitumor agent of the present invention is obtained by adding 0.5 to 5 parts by weight of alcohol to 1 part by weight of a hot water extract of a fruit body or a liquid culture hypha of Yamabushitake or a concentrated solution thereof.
The alcohol precipitate fraction produced is characterized as an active ingredient.

【0007】[0007]

【作用】これに用いるヤマブシタケは、ヘリシウム エ
リナセウス(Hericium erina- ceus)に属するものであ
ればどれでも良い。なお、抗腫瘍効果については以下の
実施例にて具体的に示した。
The yamabushitake used for this purpose may be any of those belonging to Hericium erina- ceus . The antitumor effect was specifically shown in the following examples.

【0008】ヤマブシタケについて抗腫瘍作用は伝承的
には言われてきたが、研究レベルで確認されたことはな
く、活性本体も明らかではない。また子実体は成長速度
が遅いため、工業的にこれらの作用物質を得ることは経
済性に問題点を有していた。また培養菌糸の抗腫瘍作用
については全く知られていなかった。
Although the antitumor effect of Yamabushitake has been traditionally described, it has not been confirmed at the research level, and the active substance is not clear. Further, since the fruiting body has a low growth rate, industrially obtaining these active substances has a problem in economical efficiency. Moreover, the antitumor effect of the cultured mycelium was not known at all.

【0009】液体培養の培地は特に限定するものではな
く、一般に用いられているキノコ用培地組成のいずれで
も良いが、特に酵母エキスとグルコースを用いると良い
結果が得られる。一方、空気(酸素)の存在は培養速度
を速めるために必須である。少な過ぎると菌糸の成長が
遅く、多過ぎると自己消化が起こり菌糸の収量が低下す
る。一般には0.1vvmから1vvm程度が適している(vvm は
対培地容量当りの1分間当り空気(酸素)供給量を表わ
す)。このようにして得た菌糸及び子実体の熱水抽出液
にメタノール、エタノール、またはイソプロピルアルコ
ール等のアルコールを対熱水抽出液あるいはその濃縮液
の1重量部当り 0.5〜5重量部加え、生成するアルコー
ル沈殿画分を乾燥することにより、本発明の抗腫瘍成分
を得ることができる。
The culture medium for liquid culture is not particularly limited, and any of the commonly used mushroom medium compositions may be used. Particularly, good results can be obtained by using yeast extract and glucose. On the other hand, the presence of air (oxygen) is essential to increase the culture speed. If the amount is too small, the growth of mycelium is slow, and if it is too large, autolysis occurs and the yield of mycelium decreases. Generally, about 0.1 vvm to 1 vvm is suitable (vvm represents air (oxygen) supply per minute per medium volume). An alcohol such as methanol, ethanol, or isopropyl alcohol is added to the hot water extract of the mycelium and the fruiting body thus obtained in an amount of 0.5 to 5 parts by weight per 1 part by weight of the hot water extract or a concentrate thereof to produce. Alcow
By drying the precipitate fraction, the antitumor component of the present invention can be obtained.

【0010】ヤマブシタケの抗腫瘍効果は実施例に示す
ようにマクロファージの腫瘍細胞増殖抑制効果あるいは
マウスに移植した固形腫瘍の径の変化から判定した。
[0010] The antitumor effect of Yamabushitake was determined from the tumor cell growth inhibitory effect of macrophages or changes in the diameter of solid tumors implanted in mice as shown in the Examples.

【0011】[0011]

【実施例】【Example】

(実施例1) 子実体中の抗腫瘍成分の取得:ヤマブシタケ子実体を湿
菌体のままホモジナイズし、湿菌体重量の10倍量の水を
加え、1時間熱水抽出し、抽出液を濃縮する。この濃縮
液にメタノールを加え、生成した沈澱物を遠心分離し、
次にこの沈澱物を水に溶解し、溶解液を凍結乾燥させ、
灰褐色の粉末を得た。これをサンプルAとする。
(Example 1) Acquisition of antitumor component in fruiting body: Yamabushitake fruiting body was homogenized as wet cells, added with 10 times the amount of wet cell weight of water, extracted with hot water for 1 hour, and extracted. Concentrate. Methanol was added to the concentrate, and the resulting precipitate was centrifuged.
Next, the precipitate is dissolved in water, and the solution is freeze-dried.
A gray-brown powder was obtained. This is designated as Sample A.

【0012】(実施例2) 液体培養菌糸中の抗腫瘍成分の取得:ヤマブシタケ種菌
を酵母エキス1重量%、グルコース3重量%、pH5の培
地1.5リットルの入った 2.6リットルジャーに植菌し25
℃,空気0.3vvm通気下で7日間培養後、遠心分離あるい
は濾過操作によって菌糸体を分離した。この菌糸体を湿
菌体のままホモジナイズし、湿菌体重量の10倍量の水を
加え、1時間熱水抽出し、抽出液を濃縮する。この濃縮
液にメタノールを加え、生成した沈澱物を遠心分離し、
次にこの沈澱物を水に溶解し、溶解液を凍結乾燥させ、
褐色の粉末を得た。これをサンプルBとする。
(Example 2) Acquisition of antitumor component in liquid culture mycelium: Inoculation of Yamabushitake inoculum in a 2.6 liter jar containing 1.5 liter of 1% by weight of yeast extract, 3% by weight of glucose, and pH 5 medium 25
After culturing for 7 days at 0.3 ° C. in air at 0.3 ° C., mycelium was separated by centrifugation or filtration. The mycelium is homogenized as wet cells, water is added in an amount 10 times the weight of the wet cells, hot water is extracted for 1 hour, and the extract is concentrated. Methanol was added to the concentrate, and the resulting precipitate was centrifuged.
The precipitate is then dissolved in water, the lysate is lyophilized,
A brown powder was obtained. This is designated as Sample B.

【0013】(実施例3) マクロファージの腫瘍細胞増殖抑制試験:96穴プレート
に、チオグリコレート培地で誘導したマウス腹腔内滲出
細胞と試料、そして標的細胞としてマウス肥満細胞系腫
瘍培養細胞 P815 を加え、46時間培養した後、トリチウ
ムチミジンを加え、さらに2時間培養した。培養終了
後、P815 細胞を濾紙上に採取し、 P815 細胞に取り込
まれたトリチウムを液体シンチレーションカウンターで
測定することにより、マクロファージの P815 細胞増殖
抑制作用を測定した。結果を表1の示す。
Example 3 Macrophage Tumor Cell Growth Inhibition Test: To 96-well plate, mouse peritoneal exudate cells and sample induced with thioglycolate medium, and mouse mast cell tumor culture cell P815 as target cells were added. After culturing for 46 hours, tritium thymidine was added, and the cells were further cultured for 2 hours. After completion of the culture, the P815 cells were collected on a filter paper, and the tritium incorporated in the P815 cells was measured with a liquid scintillation counter to measure the P815 cell proliferation inhibitory effect of macrophages. The results are shown in Table 1.

【0014】[0014]

【表1】 [Table 1]

【0015】上に示したようにヤマブシタケ子実体およ
び培養菌糸の熱水抽出−アルコール沈澱成分は、市販の
キノコ制癌剤であるレンチナンやクレスチンより強くマ
クロファージの細胞増殖抑制作用を活性化させた。
As shown above, the hot-water-extraction-alcohol-precipitating components of the fruit body of Yamabushitake and the cultured mycelium activated the cell growth inhibitory action of macrophages more strongly than the commercially available mushroom carcinogens Lentinan and Krestin.

【0016】(実施例4) サルコーマ 180固形腫瘍に対する効果:ICRマウス腹
腔内で増殖させたサルコーマ 180の腹水腫瘍細胞をIC
Rマウスの腋窩部皮下に1×106 細胞/匹移植し、移
植24時間後より、本発明の抗腫瘍剤を腹腔内に投与し
た。投与回数は1日1回10日間とし、移植4週間後に腫
瘍径(短径および長径)を測定し、積を算出し、それを
対照群と比較して腫瘍抑制率を算出した。また6週間後
には、腫瘍完全退縮割合を調べた。結果を表2に示す。
(Example 4) Effect on sarcoma 180 solid tumor: Ascites tumor cells of sarcoma 180 grown intraperitoneally in ICR mice were treated with IC
1 × 10 6 cells / animal were implanted subcutaneously in the axilla of R mice, and the antitumor agent of the present invention was intraperitoneally administered 24 hours after the implantation. The administration frequency was once a day for 10 days. Four weeks after transplantation, the tumor diameter (short diameter and long diameter) was measured, the product was calculated, and the product was compared with the control group to calculate the tumor suppression rate. Six weeks later, the percentage of complete tumor regression was examined. Table 2 shows the results.

【0017】[0017]

【表2】 [Table 2]

【0018】なお、投与した抗腫瘍剤は生理食塩水に懸
濁させたものを用い、対照群には生理食塩水のみを投与
した。
The administered antitumor agent was used in the form of a suspension in physiological saline, and the control group received only physiological saline.

【0019】[0019]

【発明の効果】上記実施例の示すようにヤマブシタケ子
実体および培養菌糸の熱水抽出−アルコール沈澱物は強
力な抗腫瘍剤として使用できることを認め本発明を完成
した。
As shown in the above Examples, the present invention has been completed by recognizing that the hot water extraction-alcohol precipitate of the fruit body of Yamabushitake and cultured mycelium can be used as a powerful antitumor agent.

【0020】参考としてヤマブシタケ子実体および培養
菌糸の熱水抽出−アルコール沈澱物(サンプルAおよび
B)の赤外チャートを添付した。
For reference, an infrared chart of hot water extraction of alcoholic fruit bodies of Yamabushitake and cultured mycelia (samples A and B) is attached.

【図面の簡単な説明】[Brief description of the drawings]

【図1】実施例1で得られたサンプルAの赤外線チャー
トである。
FIG. 1 is an infrared chart of Sample A obtained in Example 1.

【図2】実施例2で得られたサンプルBの赤外線チャー
トである。
FIG. 2 is an infrared chart of Sample B obtained in Example 2.

───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.7,DB名) A61K 35/84 A61P 35/00 BIOSIS(DIALOG) CA(STN) MEDLINE(STN)──────────────────────────────────────────────────続 き Continued on the front page (58) Fields surveyed (Int. Cl. 7 , DB name) A61K 35/84 A61P 35/00 BIOSIS (DIALOG) CA (STN) MEDLINE (STN)

Claims (5)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 ヤマブシタケの子実体の熱水抽出液また
はその濃縮液1重量部に対し 0.5〜5重量部のアルコー
ルを加え、生成するアルコール沈殿画分を有効成分とし
て含有することから成る抗腫瘍剤。
1. An antitumor comprising adding 0.5 to 5 parts by weight of alcohol to 1 part by weight of a hot water extract of a fruiting body of Yamabushitake or a concentrated liquid thereof, and containing an alcohol precipitated fraction as an active ingredient. Agent.
【請求項2】 ヤマブシタケの子実体の熱水抽出液また
はその濃縮液1重量部に対し 0.5〜5重量部のアルコー
ルを加え、生成するアルコール沈殿画分を有効成分とし
て含有することから成る抗腫瘍剤の製法。
2. An antitumor comprising adding 0.5 to 5 parts by weight of alcohol to 1 part by weight of a hot water extract of a fruit body of Yamabushitake or a concentrated solution thereof, and containing an alcohol precipitated fraction as an active ingredient. Formulation of the agent.
【請求項3】 ヤマブシタケの液体培養菌糸の熱水抽出
液またはその濃縮液1重量部に対し 0.5〜5重量部のア
ルコールを加え、生成するアルコール沈殿画分を有効成
分として含有することから成る抗腫瘍剤。
3. An antibacterial method comprising adding 0.5 to 5 parts by weight of alcohol to 1 part by weight of a hot water extract of a liquid culture mycelium of Yamabushitake or a concentrated liquid thereof, and containing an alcohol precipitated fraction as an active ingredient. Tumor agents.
【請求項4】 ヤマブシタケの液体培養菌糸の熱水抽出
液またはその濃縮液1重量部に対し 0.5〜5重量部のア
ルコールを加え、生成するアルコール沈殿画分を有効成
分として含有することから成る抗腫瘍剤の製法。
4. An antibacterial method comprising adding 0.5 to 5 parts by weight of alcohol to 1 part by weight of a hot water extract of a liquid culture mycelium of Yamabushitake or a concentrated liquid thereof and containing an alcohol precipitated fraction as an active ingredient. Formulation of tumor agents.
【請求項5】 アルコールがメタノール、エタノールま
たはイソプロピルアルコールのいずれかである請求項1
〜4記載の抗腫瘍剤または抗腫瘍剤の製法。
5. The method according to claim 1, wherein the alcohol is methanol, ethanol or isopropyl alcohol.
5. The method for producing an antitumor agent or an antitumor agent according to any one of claims 1 to 4.
JP18809991A 1991-07-02 1991-07-02 Antitumor agent and method for producing the same Expired - Fee Related JP3152402B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP18809991A JP3152402B2 (en) 1991-07-02 1991-07-02 Antitumor agent and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18809991A JP3152402B2 (en) 1991-07-02 1991-07-02 Antitumor agent and method for producing the same

Publications (2)

Publication Number Publication Date
JPH0517366A JPH0517366A (en) 1993-01-26
JP3152402B2 true JP3152402B2 (en) 2001-04-03

Family

ID=16217687

Family Applications (1)

Application Number Title Priority Date Filing Date
JP18809991A Expired - Fee Related JP3152402B2 (en) 1991-07-02 1991-07-02 Antitumor agent and method for producing the same

Country Status (1)

Country Link
JP (1) JP3152402B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7433591B2 (en) 2020-12-11 2024-02-20 株式会社小坂研究所 Surface texture measurement method and surface texture measurement device for ball screw thread grooves

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101040236B1 (en) * 2008-08-04 2011-06-16 (주)에이치케이바이오텍 Extracts of Mushroom Mycelial Liquid Culture Having Anticancer Effect and Manufacturing Method Thereof
CN113812487A (en) * 2021-09-29 2021-12-21 天津市农业科学院 Tea bag with stomach nourishing and digestion promoting functions and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7433591B2 (en) 2020-12-11 2024-02-20 株式会社小坂研究所 Surface texture measurement method and surface texture measurement device for ball screw thread grooves

Also Published As

Publication number Publication date
JPH0517366A (en) 1993-01-26

Similar Documents

Publication Publication Date Title
US9249438B2 (en) Production of fungal extracellular immune stimulating compounds
WO2001032830A2 (en) Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom
JP2003081863A (en) Bioactive substance of mycelium of antrodia camphorata, its compositional substance and method for producing the same
CN105815112A (en) Mushroom culture method, cultured mushrooms and pharmaceutical composition containing mushrooms
JPH01228480A (en) Production of extract of cultured mycelia of edible basidiomycete
US4140578A (en) Method of producing polysaccharides
Bisko et al. Effects of cultivation parameters on intracellular polysaccharide production in submerged culture of the edible medicinal mushroom Lentinula edodes.
CN112940145A (en) Method for extracting and preparing animal ganoderma lucidum polysaccharide
CN112501029A (en) Armillaria matsutake and method for producing ergothioneine by using same
JP4032372B2 (en) Anticancer substance
JP3152402B2 (en) Antitumor agent and method for producing the same
CN108588142B (en) Method for improving polysaccharide content of ganoderma lucidum mycelia by utilizing fungal polysaccharide and ganoderma lucidum product obtained by method
CN102178701B (en) Preparation method of polysaccharide composite with antitumor activity
KR20010046778A (en) Polymer obtained from Phellinus linteus basidiocarp and mycelial and process for preparation thereof
KR100398677B1 (en) Cultivation Method of mushroom mycelium using citrus juice and mushroom mycelium thereof
KR20180065178A (en) A composition of hydrogel mask pack using mushroom mycelium and hydrogel mask pack containing the same as an active ingredient
JP2002272267A (en) Method for artificially culturing plant worm and extracted composition of isaria japonica and functional food using the same
KR20200095208A (en) Co-culture method of mushroom mycelium
WO2019148419A1 (en) Method for improving yield of edible and medicinal fungus exopolysaccharide by adding tyrosine
JPH11209301A (en) Protein polysaccharide 0041
CN103285047B (en) Oudemansiella radicata protein extract and anti-tumor application thereof
CN103272216A (en) Pleurotus citrinopileatus protein extractive and application thereof in tumor resisting
JPH08208704A (en) New sugar-protein conjugate, its production, and antitumor agent, immunocontrolling agent, and growth factor inhibitor
CN109481477B (en) Preparation method and application of color-conversion hypha pericarp alcohol extract of mushroom hypha
Rozsa Correlation between soluble dry matter and β-1.3 d-glucan content in Agaricus Blazei Murrill mushrooms

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees